Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the vaccination of healthy cattle against disease caused by Clostridium chauvoei, C. septicum, C. haemolyticum, C. novyi, C. sordellii, C. tetani, and C. perfringens Types C & D.
LEARN MOREAn aid in the prevention of pneumonia, diarrhea, septicemia and mortality caused by Salmonella Choleraesuis and as an aid in control of disease caused by…
LEARN MORE